capgemini

Tipico is Germany's leading sports betting provider and one of the most dynamic technology companies in the gaming industry. Founded in 2004 and headquartered in St. Julian's, Malta, Tipico has grown to employ over 3,800 people across nine global locations including Germany, Croatia, Austria, and Gibraltar. Every day, Tipico's systems process millions of real-time bets - a transactional volume comparable to the world's largest financial exchanges. As a sport-tech company with a clear stance - fair, fast, and reliable - Tipico combines digital innovation with one of the strongest betting technologies in the market. The company operates more than 1,250 retail shops while maintaining a cutting-edge digital platform that serves millions of customers. Tipico's mission is to excite the sports betting experience for every customer, every bet, while maintaining the highest standards of player protection and responsible gaming.

In 1998, Capco was founded with a singular vision: to transform how financial services and energy companies navigate complexity. Born from the recognition that traditional consulting wasn't meeting the evolving needs of global financial institutions, Capco set out to create a different kind of consultancy - one that operated at the intersection of business and technology, combining innovative thinking with deep industry expertise. What started as a bold idea has grown into a global powerhouse with over 100 clients across the Americas, Europe, and Asia Pacific. Today, as a Wipro company, Capco stands as a global technology and management consultancy specializing in digital transformation across banking and payments, capital markets, wealth and asset management, insurance, and the energy sector. The firm's award-winning "Be Yourself At Work" culture fuels cutting-edge ingenuity through Innovation Labs and diverse talent, enabling Capco to deliver end-to-end data-driven solutions that fast-track digital initiatives. With offices in leading financial centers worldwide, Capco continues to challenge the status quo, building lasting strategic partnerships that foster collaboration and trust while reshaping the competitive landscape of financial services.

At Bunge, we believe our strength lies in our passionate, bold, and driven teams who work collaboratively across the globe to connect farmers to consumers. With more than 200 years of experience, our approximately 37,000 colleagues operate as One Team - fostering inclusion, collaboration, and respect - while driving for excellence through agility, innovation, and efficiency. We're people who see change as an opportunity to evolve, who enjoy taking ownership of our work, and who embrace meaningful purpose in everything we do. Our culture is built on doing what's right: acting safely, ethically, and sustainably as we deliver essential food, feed, and fuel to the world. We listen, empower, develop, and reward our people with programs that enhance our workplace environment - from diversity and inclusion initiatives to career development and wellness resources. Whether you're in grain origination, oilseed processing, or creating innovative plant-based solutions, you'll find a team that leads the way while staying grounded in integrity and sustainability.

In 1928, when automotive innovation was in its infancy, the Borg-Warner Corporation was formed through the union of four pioneering companies: Borg & Beck, Marvel-Schebler, Warner Gear, and Mechanics Universal Joint. For over 130 years, this legacy of engineering excellence has propelled BorgWarner forward, transforming from a leader in conventional propulsion technologies into a global force in sustainable mobility. Today, the company designs and manufactures the systems that define the way the world moves forward, partnering with the world's foremost technologists, engineers, and OEMs to accelerate the transition to clean mobility. Guided by a vision of a clean, energy-efficient world, BorgWarner has strategically evolved through bold acquisitions like Delphi Technologies, AKASOL, and Rhombus, expanding its electric vehicle portfolio while maintaining its foundational strengths in propulsion. The company's Charging Forward 2027 strategy underscores an unwavering commitment to carbon neutrality by 2035, positioning BorgWarner at the forefront of electrification with innovative solutions like battery management systems, electric drive modules, and high-voltage heaters. With a global footprint spanning manufacturing facilities across 19 countries, BorgWarner's culture of inclusion, integrity, excellence, responsibility, and collaboration drives its team of innovators to deliver technologies that create a cleaner, healthier, and safer future for all.

At Galderma, we've been dedicated to skin health for over 40 years. Founded in 1981, we're the only truly scaled pure-play dermatology company, working exclusively with the human body's largest organ. Our 7,000+ employees across approximately 90 countries deliver science-based solutions across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. We achieved 4.410 billion USD in net sales in 2024, reflecting our leadership position in the dermatology market. We believe everyone's skin story is unique. That's why we've built a portfolio of premium brands that meet diverse individual needs. From our roots as a joint venture between Nestlé and L'Oréal, to becoming the world's largest independent global dermatology company in 2019, and our IPO on the SIX Swiss Exchange in 2024, we've remained focused on advancing dermatology through innovation, scientific rigor, and partnership with healthcare professionals. Our unique Integrated Dermatology Strategy drives our growth as we continue developing breakthrough treatments and training programs through our Global Aesthetic Injector Network.

Chiesi is one of the top 50 pharmaceutical companies globally, with over 90 years of experience transforming patient care through innovative therapeutic solutions. Headquartered in Parma, Italy, this research-oriented international biopharmaceutical group employs more than 8,000 people across 31 countries, united by a singular purpose: promoting a healthier world for people, patients, and the planet. As a family-owned company now in its third generation, Chiesi has developed expertise in respiratory health, neonatology, special care, and rare diseases - touching millions of lives through groundbreaking medicines and treatments. In 2019, Chiesi became the world's largest pharmaceutical group certified as a B Corp, demonstrating its commitment to meeting high standards of social and environmental performance. The company operates as a Benefit Corporation, embedding sustainability directly into its bylaws and continuously measuring its impact on patients, the planet, and communities. With over €3 billion in global sales and a 10% year-over-year growth, Chiesi has established itself as a leader in biotech innovation, including opening a state-of-the-art Biotech Center of Excellence in 2024. Their pipeline spans lysosomal storage diseases, rare hematology, ophthalmology disorders, and rare immunodeficiencies, ensuring that no patient is left behind.